Error loading player: No playable sources found
ITuC1
Pharmacy and 340B Impacts: Panel Discussion - NTTAP Featured
Date
October 19, 2021
Explore related products in the following collection:
This session features a subject matter expert panel discussion with health center pharmacists and thought leaders on all things pharmacy operations. Over the past 12 months, health centers have encountered continued attacks on the 340B program by pharmaceutical manufacturers; this has increased the need for heightened awareness and mitigation of these threats and attacks. This has also led to an increase in the development of in-house pharmacies as well as a laser-focused review of contract pharmacy relationships. Panelists will focus on recommendations health center leaders should consider as they maneuver this increasingly challenging environment.
Learning Objectives
- Identify the most recent 340B policy and operational developments impacting health center pharmacy access and operations.
- Discuss new challenges for health centers as some implement in-house pharmacies and reassess contract pharmacy relationships.
- Highlight new approaches to addressing inquiries from pharmaceutical manufacturers.
Speakers
Brandon L. Jones, MHA
Director, Health Center Operations Training, NACHC
Logan Yoho, PharmD, RPh, BCACP
Director of Pharmacy, Hopewell Health Centers, Inc.
Jangus Whitner, PharmD, BCACP
Director of Pharmacy Services, PrimaryOne Health
Tim Mallett, RPh, 340B ACE
Vice President, Pharmacy Services, NACHC 340B Consultant, 340Basics
Tracks
Related Products
Leveraging HRSA Funding for Post-COVID Growth - NTTAP Featured
As part of the American Rescue Plan, HRSA’s capital grant opportunities provide health centers with funding to support construction, expansion, alteration, renovation, and other capital improvements to modify, enhance, and expand health care facilities…
